AXGN
AXGN
NASDAQ · Health Care

Axogen Inc

$49.96
+1.21 (+2.48%)
As of Nov 7, 1:44 AM ET ·
Financial Highlights (FY 2026)
Revenue
285.04M
Net Income
-19,874,868
Gross Margin
74.3%
Profit Margin
-7.0%
Rev Growth
+17.6%
D/E Ratio
0.38
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 285.04M 242.46M 948.34M 1.09B
Gross Profit 211.81M 180.17M 471.45M 543.24M
Operating Income -9,947,835 -7,615,729 102.11M 94.06M
Net Income -19,874,868 -15,215,533 77.32M 101.42M
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Rev Growth +17.6% +17.6% +5.7% +24.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 397.77M 397.77M 208.98M 163.48M
Total Equity 1.06B 1.06B 1.19B 1.27B
D/E Ratio 0.38 0.38 0.18 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,503,729 -1,215,160 143.45M 157.61M
Free Cash Flow — — 51.25M 59.12M